Nexo
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
Nexo operates in biotechnology, life science, therapeutics based in Greater Denver Area, Western US, founded in 2022.
Its activity falls under biotechnology, life science, therapeutics; the profile below is assembled from public directory data.
Greater Denver Area, Western US is where the company is located.
Its current recorded stage is Series_A.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $60M in funding.
| Sector | Biotechnology, Life Science, Therapeutics |
|---|---|
| Headquarters | Greater Denver Area, Western US |
| Founded | 2022 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $60,000,000 |
Website: www.nexotx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account